Zura Bio Limited成立于2022年1月。该公司是一家临床阶段、多资产免疫学公司，致力于为一系列未满足需求的自身免疫和炎症性疾病开发新型双通路抗体。凭借团队的丰富经验，公司识别相关疾病，并在这些疾病中开发差异化资产。公司战略重点是利用双通路生物的力量，为自身免疫性和炎症性疾病患者提供更广泛、更深层次的临床获益。
董事
名称
职位
Amit D. Munshi
Chairman of the Board
Robert Lisicki
Chief Executive Officer and Director
Arnout Ploos van Amstel
Independent Director
Daniel Becker
Independent Director
Jennifer Ann Jarrett
Independent Director
Neil Graham
Independent Director
Sandeep C. Kulkarni
Independent Director
Steven J. Schoch
Independent Director
Someit Sidhu
Director
股东
名称
职位
Robert Lisicki
Chief Executive Officer and Director
Kimberly Ann Davis
Chief Operating Officer, Secretary and Chief Legal Officer